B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Tak 733

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tak 733, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

mirdametinib
3 shared targets
avutometinib
3 shared targets
binimetinib
2 shared targets
cobimetinib
2 shared targets
trametinib
2 shared targets · score 45.1
ci
2 shared targets
selumetinib
2 shared targets
tak
2 shared targets
linsitinib
3 shared targets
orantinib
3 shared targets
Loading evidence profile...

This evidence profile for Tak 733 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.